Aytu Biopharma, Inc.
AYTU
$1.26
$0.000.00%
| Weiss Ratings | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.70 | |||
| Price History | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -24.55% | |||
| 60-Day Total Return | -18.71% | |||
| 90-Day Total Return | -36.84% | |||
| Year to Date Total Return | -25.97% | |||
| 1-Year Total Return | -60.00% | |||
| 2-Year Total Return | -48.57% | |||
| 3-Year Total Return | -94.27% | |||
| 5-Year Total Return | -99.66% | |||
| 52-Week High % Change | -63.45% | |||
| 52-Week Low % Change | 2.44% | |||
| Price | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.45 | |||
| 52-Week Low Price | $1.23 | |||
| 52-Week Low Price (Date) | Mar 07, 2025 | |||
| 52-Week High Price (Date) | May 14, 2024 | |||
| Valuation | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 7.77M | |||
| Enterprise Value | 4.52M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.76 | |||
| Earnings Per Share Growth | -56.43% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.16 | |||
| Price/Book (Q) | 0.25 | |||
| Enterprise Value/Revenue (TTM) | 0.07 | |||
| Price | $1.26 | |||
| Enterprise Value/EBITDA (TTM) | 1.46 | |||
| Enterprise Value/EBIT | -1.27 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 8.49M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (720) 437-6580 | |||
| Address | Denver Corporate Center III Denver, CO 80237 | |||
| Website | aytubio.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -5.15% | |||
| Profit Margin | -7.62% | |||
| Management Effectiveness | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1.79% | |||
| Return on Equity | -- | |||
| Income Statement | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 68.76M | |||
| Total Revenue (TTM) | 68.76M | |||
| Revenue Per Share | $8.10 | |||
| Gross Profit (TTM) | 47.10M | |||
| EBITDA (TTM) | 3.09M | |||
| EBIT (TTM) | -3.54M | |||
| Net Income (TTM) | -5.24M | |||
| Net Income Avl. to Common (TTM) | -5.24M | |||
| Total Revenue Growth (Q YOY) | -13.48% | |||
| Earnings Growth (Q YOY) | 7.43% | |||
| EPS Diluted (TTM) | -1.76 | |||
| EPS Diluted Growth (Q YOY) | -523.75% | |||
| Balance Sheet | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 20.40M | |||
| Cash Per Share (Q) | $2.40 | |||
| Total Current Assets (Q) | 63.05M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 30.77M | |||
| Current Ratio (Q) | 0.984 | |||
| Book Value Per Share (Q) | $4.99 | |||
| Total Assets (Q) | 116.23M | |||
| Total Current Liabilities (Q) | 64.05M | |||
| Total Debt (Q) | 17.14M | |||
| Total Liabilities (Q) | 85.46M | |||
| Total Common Equity (Q) | 30.77M | |||
| Cash Flow | AYTU - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 447.00K | |||
| Cash from Financing (TTM) | -251.00K | |||
| Net Change in Cash (TTM) | 869.00K | |||
| Levered Free Cash Flow (TTM) | 7.56M | |||
| Cash from Operations (TTM) | 673.00K | |||
